Curis | CRIS - Créances Commerciales





Créances Commerciales Changement Date
Alaunos Therapeutics USD 2K 0 2025-06
Amgen USD 9.57B 1.08B 2025-12
AstraZeneca USD 19.05B 1.49B 2025-12
Bayer EUR 14.19B 720M 2025-12
Bristol-Myers Squibb USD 14.62B 485M 2025-09
CSL USD 4.32B 1.35B 2025-12
Curis USD 2.55M 400K 2024-06
Eli Lilly USD 19.46B 2.25B 2025-09
Exelixis USD 286.92M 24.38M 2025-12
Gilead Sciences USD 4.91B 182M 2025-12
GlaxoSmithKline GBP 7.76B 545M 2025-12
Incyte USD 1.02B 128.52M 2025-12
Merck USD 12.12B 596M 2025-09
Novartis USD 12.29B 3.3B 2025-12
Pfizer USD 18.12B 2.02B 2025-09
Roche Holding CHF 11.9B 460M 2025-12
Sanofi EUR 397M 100M 2025-12
Takeda JPY 757.92B 55.68B 2025-12
TG Therapeutics USD 265.38M 33.86M 2025-09
Verastem USD 9.01M 8.81M 2025-12
Xoma USD 14.78M 4.96M 2024-06